Monitoring Life Obtains Medical Device Manufacturing License from AEMPS Copy

Introduction

December marks an important milestone for Monitoring Life.

Our company has officially obtained the Medical Device Manufacturing License from AEMPS—a key step forward in its mission to transform digital health and chronic patient monitoring.

What This Milestone Means

This achievement confirms that Monitoring Life meets the highest standards in quality and safety for medical device manufacturing.

It represents:

• Validation of operational processes aligned with ISO 13485 standards

• A clear path toward full certification

• Authorization to move forward with regulated production

Advancing Sensocor ML

This license enables the next phase for Sensocor ML, the company’s multisensor device designed for heart failure monitoring.

With this milestone, Monitoring Life can now:

• Scale production under regulatory compliance

• Accelerate clinical and commercial deployment

• Strengthen trust in its technology

AI-driven analytics help businesses process vast amounts of data, providing actionable insights. Companies can make more informed decisions based on real-time data, improving efficiency and reducing risks.

Looking Ahead

This is more than a regulatory step—it’s a signal of progress.

Monitoring Life continues to move toward a clear goal: delivering reliable, scalable solutions that improve the lives of millions of patients.

The journey is just beginning.